EU drugs regulator studying expanded use of COVID-19 drug remdesivir

FILE PHOTO: A lab technicians holds the coronavirus disease (COVID-19) treatment drug “Remdesivir” at Eva Pharma Facility in Cairo, Egypt June 25, 2020. REUTERS/Amr Abdallah Dalsh/File Photo

(Reuters) – Europe’s drugs regulator said on Tuesday it is evaluating the use of remdesivir in COVID-19 patients who do not need oxygen support, after developer Gilead Sciences submitted an application to extend the medicine’s use.

Europe had conditionally approved remdesivir, sold under the brand name Veklury, in July for treating COVID-19 in adults and adolescents with pneumonia requiring oxygen support.

Source: Read Full Article